METROPOLIS.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 09:34):

Stats
Šios dienos apimtis	45 077.00
Vidutinė apimtis	388 837
Rinkos kapitalizacija	91.85B
EPS	INR0 ( 2024-02-04 )
Kita pelno data	( INR13.40 ) 2024-05-13
Last Dividend	INR8.00 ( 2023-02-23 )
Next Dividend	INR0 ( N/A )
P/E	73.57
ATR14	INR0.739 (0.04%)

Tūris Koreliacija

Ilgas: -0.10 (neutral)

Trumpas: 0.14 (neutral)

Signal:(74.527) Neutral

Metropolis Healthcare Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Metropolis Healthcare Koreliacija - Valiuta/Žaliavos

0.43
( neutral )

0.67
( moderate )

0.58
( weak )

-0.19
( neutral )

0.06
( neutral )

-0.63
( weak negative )

Metropolis Healthcare Finansinės ataskaitos

Annual	2022
Pajamos:	INR11.48B
Bruto pelnas:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
Pajamos:	INR11.48B
Bruto pelnas:	INR8.88B (77.37 %)
EPS:	INR27.91

FY	2022
Pajamos:	INR12.28B
Bruto pelnas:	INR9.41B (76.59 %)
EPS:	INR41.87

FY	2021
Pajamos:	INR9.98B
Bruto pelnas:	INR7.38B (73.92 %)
EPS:	INR35.97

Financial Reports:

No articles found.

Metropolis Healthcare Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Metropolis Healthcare Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.98 - low (32.22%) | Divividend Growth Potential Score: 3.79 - Decrease likely (24.28%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR8.00	2020-02-13
Last Dividend	INR8.00	2023-02-23
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR32.00	--
Avg. Dividend % Per Year	0.30%	--
Score	1.82	--
Div. Sustainability Score	3.98
Div.Growth Potential Score	3.79
Div. Directional Score	3.88	--

Next Divdend (Est)
(2024-12-31)

INR0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

1.82

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR8.00	0.56%
2021	INR8.00	0.40%
2022	INR8.00	0.23%
2023	INR8.00	0.61%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
TDPOWERSYS.NS	Dividend Junior	2023-08-02	Annually	13	0.31%
OLECTRA.NS	Dividend Junior	2023-09-21	Sporadic	23	0.03%
INTENTECH.NS	Dividend Junior	2023-09-21	Annually	6	0.44%
COROMANDEL.NS	Dividend Knight	2023-07-13	Annually	19	1.02%
SHALBY.NS	Dividend Junior	2023-08-08	Annually	6	0.51%
MANALIPETC.NS	Dividend Junior	2023-09-15	Annually	18	1.50%
GPPL.NS	Dividend Knight	2023-07-26	Semi-Annually	9	2.89%
AXISBANK.NS	Dividend Junior	2023-07-06	Sporadic	26	0.06%
TRU.NS	Dividend Junior	2023-09-18	Annually	3	0.01%
PIXTRANS.NS	Dividend Junior	2023-07-11	Semi-Annually	3	0.43%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.108	1.500	7.85	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.122	1.500	9.75	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	8.18	1.000	8.08	8.08	[3 - 30]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.791	1.000	0.155	0.155	[0.2 - 0.8]
operatingProfitMarginTTM	0.163	1.000	8.74	8.74	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.98

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	74.11	1.000	2.62	0	[1 - 100]
returnOnEquityTTM	0.122	2.50	9.84	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.222	1.500	4.46	0	[0 - 0.4]
operatingCashFlowPerShareTTM	35.72	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.22	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.158	1.000	8.55	0	[0.1 - 0.5]
Total Score				3.79

Metropolis Healthcare

Metropolis Healthcare Limited provides diagnostic services in India. It offers clinical laboratory testing, and profiles and support services. The company provides diagnostic services for oncology, neurology, gynecology, and nephrology, as well as various health check-up packages for men, women, senior citizens, and youth and corporates. Its tests and profiles are used for prediction, early detection, diagnostic screening, confirmation, and/or monitoring of the disease. The company also offers corporate wellness and hospital laboratory solutions, as well as clinical research services. As of March 31, 2022, it operated 171 clinical laboratories, 9,000 pick-up points, and 704 assisted referral centers. The company was founded in 1980 and is headquartered in Mumbai, India.